Bausch continues debt reduction with additional $100 million paydown

Chicago, July 29 – Bausch Health Cos. Inc. put in notice to pay down an additional $100 million of its senior secured term loans this week, according to a press release.

Cash generated from operations is being used for the paydown.

After this payment, the company will have eliminated all mandatory amortization for the second quarter of 2020.

Based in Laval, Quebec, Bausch develops, manufactures and markets pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.